[go: up one dir, main page]

NO20013015D0 - Liposomine inflammatory acid - new transdermal anti-inflammatory drug - Google Patents

Liposomine inflammatory acid - new transdermal anti-inflammatory drug

Info

Publication number
NO20013015D0
NO20013015D0 NO20013015A NO20013015A NO20013015D0 NO 20013015 D0 NO20013015 D0 NO 20013015D0 NO 20013015 A NO20013015 A NO 20013015A NO 20013015 A NO20013015 A NO 20013015A NO 20013015 D0 NO20013015 D0 NO 20013015D0
Authority
NO
Norway
Prior art keywords
inflammatory
liposomine
acid
new transdermal
drug
Prior art date
Application number
NO20013015A
Other languages
Norwegian (no)
Other versions
NO20013015L (en
Inventor
Konstantinos Demetzos
Helen Kammenou
Michalis Rallis
Georgios Papaioannou
Aristidis Georgopoulos
Georgios Tsamouris
Sofia Hatziantoniou
Georgios Giannisis
Georgios Nounesis
Christina Savva Dimopoulou
Original Assignee
P N Gerolymatos Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by P N Gerolymatos Sa filed Critical P N Gerolymatos Sa
Publication of NO20013015D0 publication Critical patent/NO20013015D0/en
Publication of NO20013015L publication Critical patent/NO20013015L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • A61K9/1278Post-loading, e.g. by ion or pH gradient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
NO20013015A 1998-12-24 2001-06-18 Liposomine inflammatory acid - new transdermal anti-inflammatory drug NO20013015L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR98100469 1998-12-24
PCT/GR1999/000048 WO2000038681A1 (en) 1998-12-24 1999-12-22 Liposomic niflumic acid - new transdermal anti-inflammatory medicine

Publications (2)

Publication Number Publication Date
NO20013015D0 true NO20013015D0 (en) 2001-06-18
NO20013015L NO20013015L (en) 2001-06-18

Family

ID=10943556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013015A NO20013015L (en) 1998-12-24 2001-06-18 Liposomine inflammatory acid - new transdermal anti-inflammatory drug

Country Status (17)

Country Link
EP (1) EP1140089A1 (en)
JP (1) JP2002533394A (en)
KR (1) KR20010089889A (en)
CN (1) CN1331592A (en)
AU (1) AU1673400A (en)
BR (1) BR9917006A (en)
CA (1) CA2357765A1 (en)
CZ (1) CZ20012240A3 (en)
GR (1) GR1003359B (en)
HU (1) HUP0104853A3 (en)
IL (1) IL143499A0 (en)
IS (1) IS5964A (en)
MX (1) MXPA01006462A (en)
NO (1) NO20013015L (en)
PL (1) PL349344A1 (en)
SK (1) SK7962001A3 (en)
WO (1) WO2000038681A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2507263A1 (en) * 2002-11-26 2004-06-10 Gilead Sciences, Inc. Liposomal formulations
US9028863B2 (en) 2003-04-25 2015-05-12 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
JP4791082B2 (en) * 2005-05-30 2011-10-12 株式会社クラレ Liposomes and topical skin preparations containing the same
JP4931369B2 (en) * 2005-05-31 2012-05-16 ポーラ化成工業株式会社 Liposomes and therapeutic compositions containing the same
PL1888033T3 (en) 2005-06-09 2014-09-30 Meda Ab Method and composition for treating inflammatory disorders
BR112013003658B1 (en) 2010-07-28 2022-02-22 Life Technologies Corporation Pharmaceutical composition comprising azide-modified isoprenoid fatty acid, carbohydrate and lipid, use of such components and method of inhibiting infectivity of a virus
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
EP2807252B1 (en) 2012-01-26 2017-05-10 Life Technologies Corporation Methods for increasing the infectivity of viruses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
DE3683606D1 (en) * 1985-11-27 1992-03-05 Ethicon Inc INHIBITION OF POST-OPERATIVE ADHAESION FORMATION BY TOPICAL ADMINISTRATION OF AN INFLAMMATORY-RESISTANT NON-STEROID ACTIVE SUBSTANCE.
ES2036593T3 (en) * 1986-06-12 1993-06-01 The Liposome Company, Inc. COMPOSITIONS USING NON-STEROID ANTI-INFLAMMATORY MEDICINES ENCAPSULATED IN LIPOSOMES.
AU5557796A (en) * 1995-04-18 1996-11-07 Dehlinger, Peter J. Liposome drug-loading method and composition

Also Published As

Publication number Publication date
GR1003359B (en) 2000-04-10
HUP0104853A3 (en) 2003-05-28
PL349344A1 (en) 2002-07-15
EP1140089A1 (en) 2001-10-10
IS5964A (en) 2001-06-08
CN1331592A (en) 2002-01-16
CA2357765A1 (en) 2000-07-06
JP2002533394A (en) 2002-10-08
IL143499A0 (en) 2002-04-21
WO2000038681A1 (en) 2000-07-06
HUP0104853A2 (en) 2002-05-29
AU1673400A (en) 2000-07-31
BR9917006A (en) 2001-10-30
SK7962001A3 (en) 2002-02-05
KR20010089889A (en) 2001-10-12
NO20013015L (en) 2001-06-18
CZ20012240A3 (en) 2001-11-14
MXPA01006462A (en) 2002-06-04

Similar Documents

Publication Publication Date Title
PT966430E (en) ANTI-INFLAMMATORY COMPOUNDS
ATE285405T1 (en) NONSTEROID ANTI-INFLAMMATORY
EE200100483A (en) Compounds used as anti-inflammatory agents
IS5568A (en) Pharmacologically active morpholinol
FI991485L (en) New pharmaceutical composition
NO20015175D0 (en) Pharmaceutical composition
IS5760A (en) Therapeutic baryl derivatives
DK1637127T3 (en) THERAPEUTIC MICROSUM
NO20021400D0 (en) Therapeutic conazoline derivatives
ATE392890T1 (en) HYDROGEL-CONTROLLED DOSAGE FORM
ID27415A (en) PHARMACEUTICAL COMPOSITION
NO20031869D0 (en) Anti-inflammatory agents
FI4150U1 (en) The electrode structure
ID29262A (en) PHARMACEUTICAL COMPOSITION
ID27201A (en) PHARMACEUTICAL COMPOSITION
NO20022606D0 (en) Pharmaceutical combinations
DK1275397T3 (en) Local drug
PT1086097E (en) SULFONYLBENZENO COMPOUNDS AS ANTI-INFLAMMATORY / ANALGESIC AGENTS
ID27150A (en) PHARMACEUTICAL MATERIALS LEVOTIROXIDE
NO20014926L (en) Pharmaceutical compounds
FR2774599B1 (en) POULTICE
DE60011330D1 (en) electrode
NO20013015D0 (en) Liposomine inflammatory acid - new transdermal anti-inflammatory drug
FI4488U1 (en) Pharmaceutical composition
IS6163A (en) drugs Komplex

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application